Literature DB >> 24330069

Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity.

David J Gunn1, David W Cartwright, Glen A Gole.   

Abstract

BACKGROUND: To describe outcomes in a cohort of extremely premature infants treated for aggressive posterior retinopathy of prematurity by diode laser panretinal photocoagulation.
DESIGN: Retrospective study. PARTICIPANTS: Fifteen eyes in eight infants.
METHODS: A review was carried out on infants between 23 and 25.6 weeks gestational age admitted to The Royal Brisbane and Women's Hospital neonatal intensive care unit between 1992 and 2009. MAIN OUTCOME MEASURES: Success of treatment, visual and refractive outcomes.
RESULTS: Five hundred fifty-four infants were admitted to neonatal intensive care unit, 373 survived till screening, and 304 had retinopathy of prematurity. Sixty-six infants required treatment, and eight of these had aggressive posterior retinopathy of prematurity (2.5% of all infants with retinopathy of prematurity). Mean gestational age was 24.2 weeks, mean birthweight was 634 g, and treatment occurred at mean 34.1 weeks post-menstrual age. The mean total number of burns per eye was 2967. Five of 15 treated eyes required retreatment. Two patients subsequently died of unrelated causes. Regression occurred in 9 of 11 remaining eyes; one eye progressed to stage 4b and another to stage 5 retinopathy of prematurity. Vitrectomy was performed in two eyes. Five eyes had 6/12 vision, one had 3/60, and three had no perception of light. Of the remaining two eyes, one had good fixation and the other had poor fixation.
CONCLUSIONS: Despite good structural outcomes, visual outcomes for conventional laser treatment of aggressive posterior retinopathy of prematurity are poor.
© 2013 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  ROP; laser; prematurity

Mesh:

Year:  2014        PMID: 24330069     DOI: 10.1111/ceo.12280

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  11 in total

1.  Characteristic clinical features associated with aggressive posterior retinopathy of prematurity.

Authors:  Y J Ahn; K E Hong; H R Yum; J H Lee; K S Kim; Y A Youn; S H Park
Journal:  Eye (Lond)       Date:  2017-02-24       Impact factor: 3.775

2.  Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment.

Authors:  Shilpi H Narnaware; Prashant K Bawankule; Dhananjay Raje
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

3.  Comparison of Intravitreal Anti-VEGF Agents With Laser Photocoagulation for Retinopathy of Prematurity of 1,627 Eyes in China.

Authors:  Dandan Linghu; Yong Cheng; Xuemei Zhu; Xun Deng; Hong Yin; Yanrong Jiang; Mingwei Zhao; Xiaoxin Li; Jianhong Liang
Journal:  Front Med (Lausanne)       Date:  2022-05-31

Review 4.  Aggressive posterior retinopathy of prematurity: a review on current understanding.

Authors:  Devesh Kumawat; Anusha Sachan; Pooja Shah; Rohan Chawla; Parijat Chandra
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

Review 5.  A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.

Authors:  Laura Pertl; Gernot Steinwender; Christoph Mayer; Silke Hausberger; Eva-Maria Pöschl; Werner Wackernagel; Andreas Wedrich; Yosuf El-Shabrawi; Anton Haas
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

6.  Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity.

Authors:  Caner Kara; Emre Hekimoğlu; İkbal Seza Petriçli; Handan Akıl
Journal:  J Curr Ophthalmol       Date:  2017-08-24

7.  Retinopathy of prematurity in Ardabil, North West of Iran: Prevalence and risk factors.

Authors:  Yousef Fekri; Habib Ojaghi; Neda Momeni; Firouz Amani
Journal:  Eur J Transl Myol       Date:  2021-11-10

8.  Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab.

Authors:  Ameay V Naravane; Peter J Belin; Shaina Rubino; Polly A Quiram
Journal:  Front Pediatr       Date:  2022-02-11       Impact factor: 3.418

9.  Retinopathy of prematurity: a review of epidemiology and current treatment strategies.

Authors:  Eun Hee Hong; Yong Un Shin; Heeyoon Cho
Journal:  Clin Exp Pediatr       Date:  2021-10-12

10.  Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity.

Authors:  Yoko Fukushima; Takahiro Fujino; Shunji Kusaka; Yoshikazu Hatsukawa; Kohji Nishida
Journal:  Am J Ophthalmol Case Rep       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.